Loading...
Date of Award
Spring 2021
Degree Name
Master of Medical Science (Physician Assistant)
Department
Physician Assistant; College of Health Sciences
First Advisor
Amanda Seymour MS, PA-C
Abstract
Patients with stages III-V CKD have increased risk for cardiovascular mortality due the correlation between the renal and cardiovascular systems, partially due to hyperphosphatemia. By controlling elevated phosphate levels the risk for cardiovascular damage is reduced. This is typically managed using phosphate binders and dietary phosphate restrictions. The intention of this review is to analyze non-calcium phosphate binders efficacy in reducing serum phosphate levels therefore mitigating risk for cardiovascular comorbidities when compared to calcium-based phosphate binders in patients with III-IV CKD.
Recommended Citation
Schlagel, Scott, "Efficacy of non-calcium phosphate binders compared to calcium phosphate binders in the treatment of hyperphosphatemia in stage III-V CKD" (2021). Capstone Showcase. 71.
https://scholarworks.arcadia.edu/showcase/2021/pa/71
Efficacy of non-calcium phosphate binders compared to calcium phosphate binders in the treatment of hyperphosphatemia in stage III-V CKD
Patients with stages III-V CKD have increased risk for cardiovascular mortality due the correlation between the renal and cardiovascular systems, partially due to hyperphosphatemia. By controlling elevated phosphate levels the risk for cardiovascular damage is reduced. This is typically managed using phosphate binders and dietary phosphate restrictions. The intention of this review is to analyze non-calcium phosphate binders efficacy in reducing serum phosphate levels therefore mitigating risk for cardiovascular comorbidities when compared to calcium-based phosphate binders in patients with III-IV CKD.